disparities in collaborative patient-provider ... · disparities in collaborative patient-provider...
TRANSCRIPT
![Page 1: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/1.jpg)
Disparities in collaborative
patient-provider communication
about HPV vaccination
Jennifer L. Moss, PhD1,2, Melissa B. Gilkey, PhD3,
Barbara K. Rimer, DrPH1, Noel T. Brewer, PhD1
1University of North Carolina
2National Cancer Institute
3Harvard Medical School
May 20, 2016
![Page 2: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/2.jpg)
2
Disclosures
JLM, MBG, and BKR have no potential conflicts to report.
NTB has served on paid advisory boards or received research grants
from Merck, GSK, CDC, and FDA, and now serves as chair of the
CDC-funded National HPV Vaccination Roundtable.
This research was supported by a grant from National Cancer Institute (F31 CA189411;
PI: Moss) and data support from the National Center for Health Statistics.
Opinions do not necessarily reflect the official positions of the NCI or the NCHS.
![Page 3: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/3.jpg)
3
Introduction: HPV
Infection can lead to
Genital warts (>300k cases/yr in US)
Cancer (26k cases/yr in US)
High-priority populations
Racial/ethnic minorities
Un/underinsured
Vaccine
Lack of health disparities in uptake
Suboptimal uptake overall
U.S. HPV vaccine initiation, 2014
Girls 60%
Boys 42%
![Page 4: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/4.jpg)
4
Introduction: Patient-provider interactions
Provider recommendation
Communication style?
Paternalistic v. collaborative
Association with HPV vaccination: Mixed findings
Differences in communication style by patient characteristics
![Page 5: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/5.jpg)
5
Methods
National Immunization Survey-Teen, 2010
n=4,124 parents of girls
Measures
Collaborative communication (Charles et al., 1997, 1999, 2006)
HPV vaccine initiation (verified by healthcare providers)
Formal test of mediation (Iacobucci, 2012; Sobel, 1982)
Demographics
Collaborative
communication
HPV vaccine
initiation
![Page 6: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/6.jpg)
6
Results: Participant characteristics (n=4,124)
Non-Hispanic white 61%
Privately insured 62%
Mother with >HS degree 64%
At/above poverty 78%
Urban 85%
![Page 7: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/7.jpg)
7
Results: Communication and vaccination
Overall HPV vaccine initiation: 49%
0%
20%
40%
60%
80%
100%
Non-collaborativecommunication
Collaborativecommunication
***p<.001
% initia
ting H
PV
vaccin
e
***OR=4.70
(95% CI=4.12-5.36)
![Page 8: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/8.jpg)
8
Results: Collaborative communication
Overall prevalence = 53%
0%
20%
40%
60%
80%
100%N
H W
hite
v H
isp
an
ic
Priva
tev p
ublic
in
su
r
Mo
m >
HS
v m
om
≤ H
S
At o
r a
bove
v b
elo
w p
ov
Urb
/su
bu
rbv r
ura
l
**********
% r
eport
ing c
olla
bora
tive
com
munic
ation
*p<.05
**p<.01
***p<.001
![Page 9: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/9.jpg)
9
Results: Mediation (I) – Ethnicity
Hispanic v
non-Hispanic white
Collaborative v
non-collaborative
Vaccination v
no vaccination
-0.69* 1.07
(0.38)0.56*
Mediation z = -2.94*
Controlling for provider recommendation for vaccination.
*p<.05
![Page 10: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/10.jpg)
10
Results: Mediation (II) – Health insurance
Public v
private insurance
Collaborative v
non-collaborative
Vaccination v
no vaccination
-0.35* 1.05*
(0.28*)0.36*
Mediation z = -2.28*
Controlling for provider recommendation for vaccination.
*p<.05
![Page 11: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/11.jpg)
11
Below federal poverty level 1.83
Spanish speaking -1.40
Lower maternal education -1.14
- †
- †
Summary
Underserved
groups
Collaborative
communication
HPV vaccine
initiation
a = -
(c = +)c’ = ++
b = +
†p<.10
*p<.05Underserved group z -score for
mediation
Hispanic ethnicity -2.94*
Public insurance -2.28*
.
![Page 12: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/12.jpg)
12
Strengths and limitations
Strengths
Nationally-representative sample
Provider-verified vaccination status
Limitations
Cross-sectional analysis
Parental self-report of communication
![Page 13: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/13.jpg)
13
Conclusions
HPV vaccination
Higher when parents reported collaborative communication
Equal or higher in high-priority groups
Evident disparities in collaborative patient-provider communication
Lower in high-priority groups
Disparities in communication suppressed differences in vaccination
Equalizing communication styles across groups
could result in more favorable vaccination outcomes
overall and for high-priority groups.
![Page 14: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/14.jpg)
14
Moss, J. L., Gilkey, M. B., Rimer, B. K., & Brewer, N. T. (in press).
Disparities in collaborative patient-provider communication
about human papillomavirus (HPV) vaccination.
Human Vaccines & Immunotherapeutics.
Jennifer L. Moss, PhD
Cancer Prevention Fellow
National Cancer Institute
@Jennifer_L_Moss
![Page 15: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/15.jpg)
cpfp.cancer.gov www.cancer.gov
![Page 16: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/16.jpg)
16
Mediation results (III): Poverty
Below vabove poverty level
Collaborative v non-collaborative
Vaccination v no vaccination
-0.42* 1.55*
(0.31)0.53*
Mediation z = -2.59*
*p<.01
![Page 17: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/17.jpg)
Rural vs urban
Collaborative v non-collaborative
Vaccination v no vaccination
0.36* 1.55*
(0.18)0.08
Mediation z = 2.87*
*p<.01
Mediation results (IV): Rurality
![Page 18: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/18.jpg)
Results (V.a.): Moderation
0
10
20
30
40
50
60
70
80
Rural Urban/suburban
Perc
ent
initia
ting H
PV
vaccin
ation
No
Yes
Moderation p=.02
Non-collaborative communication
Collaborative communication
+46% +33%
![Page 19: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/19.jpg)
0
10
20
30
40
50
60
70
80
Non-Hispanicwhite
Non-Hispanicblack
Hispanic Other
Perc
en
t in
itia
ting
HP
V v
accin
ation
No
Yes
Results (V.b.): Moderation
Moderation p=.01
Non-collab.communication
Collaborative communication
+44% +16% +40% +18%
![Page 20: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/20.jpg)
20
Step 1: Demographics & vaccinationDem.
Comm.
Vacc.
0.0
0.5
1.0
1.5
2.0
2.5
Race/ethnicity Insurance Poverty
Od
ds
rati
o o
f H
PV
vac
cin
atio
n
Well-served
Underserved
Hispanic(v. non-Hispanic
white ref.)
OR=1.30
Public ins.(v. private
insurance ref.)
OR=1.11
Below pov. level(v. at/above poverty
ref.)
OR=1.36
![Page 21: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/21.jpg)
21
Step 2: Demographics & communication
0.0
0.5
1.0
1.5
2.0
2.5
Race/ethnicity Insurance Poverty
Od
ds
rati
o o
f re
po
rtin
g co
llab
. co
mm
.
Well-served
Underserved
Hispanic(v. non-Hispanic
white ref.)
OR=0.54*
Public ins.(v. private
insurance ref.)
OR=0.63**
Below pov. level(v. at/above poverty
ref.)
OR=0.66*
Dem.
Comm.
Vacc.
*p<.01**p<.001
![Page 22: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/22.jpg)
22
HPV vaccination: 49%
(OR is controlling for provider recommendation for vaccination)
Step 3: Communication & vaccinationDem.
Comm.
Vacc.
HPV vax OR (95% CI)
DID NOT report collaborative communication 31% ref.
DID report collaborative communication 66% 4.70 (4.12-5.36)
![Page 23: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/23.jpg)
23
Step 4: Demographics, communication, and vaccination
Demographics(underserved
groups)
Collaborative communication
HPV vaccination
a = -
(c = +)c’ = ++
b = +
![Page 24: Disparities in collaborative patient-provider ... · Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD1,2, Melissa B. Gilkey,](https://reader034.vdocuments.mx/reader034/viewer/2022050420/5f8fa4c6688c6c2feb73f5bc/html5/thumbnails/24.jpg)
Differences in vaccination odds
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Od
ds
rati
o o
f H
PV
vac
cin
atio
n
Hispanics (v. non-Hispanic
white ref.)z = -3.04*
Public ins. (v. private
insurance ref.) z = -3.67*
Below pov. (v. at/above poverty ref.)
z = -2.59*
*p<.01
c c' c c' c c'